Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporationverified

6932.TWO

Price:

$8.58

Market Cap:

$3.59B

Mercury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development platform to produce new dosage forms with precise time-controlled dissolution, precise site absorption, and various dosage adjustments to enhance the bio-availability of active pharmaceutical ingredients to reduce the dosage of drugs and its side effects. It develops drugs for treating erectile dysfunction, pulmonary hypertension, sleep disorder, benign prostatic hyperplasia, angina pectoris, migraine, anti-hypertension, and analgesic. The company was founded in 2019 and is based in New Taipei City, Taiwan.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2022-12-23

Stock Exchange

TWO

Ticker

6932.TWO

The ROE as of December 2025 (TTM) for Mercury Biopharmaceutical Corporation (6932.TWO) is -26.02%

According to Mercury Biopharmaceutical Corporation’s latest financial reports and current stock price. The company's current ROE is -26.02%. This represents a change of 170.89% compared to the average of -9.61% of the last 4 quarters.

Mercury Biopharmaceutical Corporation (6932.TWO) Historical ROE (quarterly & annually)

How has 6932.TWO ROE performed in the past?

The mean historical ROE of Mercury Biopharmaceutical Corporation over the last ten years is -3316.05%. The current -26.02% ROE has changed -99.22% with respect to the historical average. Over the past ten years (40 quarters), 6932.TWO's ROE was at its highest in in the June 2020 quarter at 100.96%. The ROE was at its lowest in in the June 2021 quarter at -51.81%.

Quarterly (TTM)
Annual

Average

-3316.05%

Median

-17.37%

Minimum

-19900.00%

Maximum

100.48%

Mercury Biopharmaceutical Corporation (6932.TWO) ROE by Quarter and Year

Discovering the peaks and valleys of Mercury Biopharmaceutical Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 54.41%

Maximum Annual ROE = 100.48%

Minimum Annual Increase = -150.53%

Minimum Annual ROE = -19900.00%

Quarterly (TTM)
Annual
YearROEChange
2024-17.42%54.41%
2023-11.28%-34.89%
2022-17.33%-65.87%
2021-50.77%-150.53%
2020100.48%-100.50%

Mercury Biopharmaceutical Corporation (6932.TWO) Average ROE

How has 6932.TWO ROE performed in the past?

The current ROE of Mercury Biopharmaceutical Corporation (6932.TWO) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-15.34%

5-year avg

0.73%

10-year avg

-3316.05%

Mercury Biopharmaceutical Corporation (6932.TWO) ROE vs. Peers

How is 6932.TWO’s ROE compared to its peers?

Mercury Biopharmaceutical Corporation’s ROE is greater than PhytoHealth Corporation (-3.20%), less than Maywufa Company Ltd. (8.32%), less than Johnson Chemical Pharmaceutical Works Co., Ltd. (4.49%), greater than Golden Biotechnology Corporation (-126.92%), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (-10.90%), greater than Anti-Microbial Savior BioteQ Co., Ltd (-41.50%), greater than Taiwan Bio Therapeutics Co., Ltd (-42.93%), greater than Intech Biopharm Corporation (-40.45%), greater than TaiRx, Inc. (-23.22%), greater than InnoPharmax Inc. (-18.51%),

Build a custom stock screener for Mercury Biopharmaceutical Corporation (6932.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mercury Biopharmaceutical Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mercury Biopharmaceutical Corporation (6932.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mercury Biopharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Mercury Biopharmaceutical Corporation's ROE?

How is the ROE calculated for Mercury Biopharmaceutical Corporation (6932.TWO)?

What is the highest ROE for Mercury Biopharmaceutical Corporation (6932.TWO)?

What is the 3-year average ROE for Mercury Biopharmaceutical Corporation (6932.TWO)?

What is the 5-year average ROE for Mercury Biopharmaceutical Corporation (6932.TWO)?

How does the current ROE for Mercury Biopharmaceutical Corporation (6932.TWO) compare to its historical average?